filmov
tv
Clinical Nuclear Medicine | PRRT, Lutathera and NETTER 1 trial
Показать описание
This video explains the concepts of theragnostic and Peptide receptor radionuclide therapy in the context of neuroendocrine tumours, along with discussing the NETTER-1 trial data which led to the EMA and FDA approval of Lutathera as a radiopharmaceutical of choice for PRRT in patients with GEP-NETs.
This video is presented by Miss Poulami Kumar, M.Sc Nuclear Medicine, Indian Institute of Technology Kharagpur, India.
PS: Please give your valuable feedback so that we can work more to improve and make new videos for nuclear medicine.
This video is presented by Miss Poulami Kumar, M.Sc Nuclear Medicine, Indian Institute of Technology Kharagpur, India.
PS: Please give your valuable feedback so that we can work more to improve and make new videos for nuclear medicine.
Clinical Nuclear Medicine | PRRT, Lutathera and NETTER 1 trial
0:23:11
2019PED Baum Future of PRRT
0:29:57
Prof John Buscombe - The evidence for PRRT
0:41:25
8. Nuclear Medicine for NETs, Rathan Subramaniam, MD, PhD, UT Southwestern, 2018 Houston Conference
0:34:31
NETWise Episode 4: Nuclear Medicine for NETs: PRRT- (See Episode 28 for the Updated Version)
0:00:56
Lu177 PRRT For Neuroendocrine Tumors Nets
0:20:24
2019PED Gardner PRRT Experience
0:02:26
Combining PRRT with Targeted Therapy
0:04:15
Radiopharmacy : Armor of Nuclear Medicine | AIIMS | Nuclear Medicine | New Delhi | India | Future
0:58:01
IAEA/ESNM Webinar - Basic Principles of Radionuclide Therapy and Common Clinical Applications
0:06:16
How do you determine whether PRRT is the treatment of choice for your condition?
0:24:06
Nuclear medicine for NETs, Lisa Bodei, MD, Memorial Sloan Kettering
0:07:39
PRRT Patients become our friends for Life | Nuclear Medicine Therapy
0:02:23
Nuclear Medicine Therapy | Treatment Using Nuclear Medicine | Radionuclide Therapy | PRRT |
0:31:14
Nuclear Medicine Imaging & PRRT: Louise Thomson, MD - 2019 LA NET Conf
0:04:52
Nuclear Medicine Therapy Shows Long-Term Effectiveness for Malignant Neuroendocrine Tumors
0:26:44
PRRT for NETs
0:10:11
Peptide Receptor Radionuclide Therapy (PRRT)
0:00:16
PRRT Therapy For Neuroendocrine Tumor | PRRT Treatment in India
0:04:42
Improving PRRT for Neuroendocrine Tumors (NETs)
1:03:05
PEPTIDE RECEPTOR RADIONUCLIDE THERAPY (PRRT)
0:10:25
PRRT Therapy by Dr. Ishita B Sen | Nuclear Medicine Therapy
0:19:42
NUCLEAR MEDICINE AND PRRT- WHAT IS NEW by Heather Jacene, MD, Dana-Farber Cancer Institute
1:38:39
LACNETS - 'Focus on PRRT with the UCLA PRRT Team' (UCLA)
Комментарии